Other diseases of peritoneum

K11_OTHPERITON

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 K66
  • Hospital discharge: ICD-9 568
  • Hospital discharge: ICD-8 569
  • Hospital discharge: excluded ICD-8 56902
  • Cause of death: ICD-10 K66
  • Cause of death: ICD-9 568
  • Cause of death: ICD-8 569
  • Cause of death: excluded ICD-8 56902

2 out of 7 registries used, show all original rules.

1705

4. Check minimum number of events

None

1705

5. Include endpoints

None

1705

6. Filter based on genotype QC (FinnGen only)

1705

Control definitions (FinnGen only)

Control exclude
K11_PERITON

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K65-K67
Name in latin
Aliae morbositates peritonei

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 15019 9767 5049
Only index persons 11222 7846 3376
Unadjusted period prevalence (%)
Whole population 0.23 0.28 0.14
Only index persons 0.24 0.29 0.13
Median age at first event (years)
Whole population 47.02 47.13 46.44
Only index persons 41.64 43.17 38.08

-FinnGen-

Key figures

All Female Male
Number of individuals 1705 1207 498
Unadjusted period prevalence (%) 0.36 0.41 0.22
Median age at first event (years) 42.87 42.13 44.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1563
Matched controls
15629
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K66.0
ICD-10 Finland
Peritoneal adhesions
+∞
323.0
650
*
56909
ICD-8 Finland
Other diseases of intestines and peritoneum, Unspecified
+∞
266.4
248
*
56908
ICD-8 Finland
Other diseases of intestines and peritoneum, Alii definiti
+∞
188.4
177
*
5680A
ICD-9 Finland
Other disorders of peritoneum, Peritoneal adhesions
+∞
154.8
146
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
23.9
130.8
190
90
K66.1
ICD-10 Finland
Haemoperitoneum
+∞
126.8
120
*
JAH01
NOMESCO Finland
Laparoscopy
8.7
104.0
239
318
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
102.8
813
3908
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.9
63.8
492
2139
56907
ICD-8 Finland
Other diseases of intestines and peritoneum, Prolapsus recti
+∞
54.5
52
*
UJF32
NOMESCO Finland
Coloscopy
2.4
48.3
515
2620
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
15.1
44.7
75
52
JAH00
NOMESCO Finland
Laparotomy
7.5
42.2
103
146
56906
ICD-8 Finland
Other diseases of intestines and peritoneum, Prolapsus ani
+∞
41.8
40
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
9.6
41.3
86
94
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
4.2
40.2
164
426
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
39.8
248
905
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
39.0
339
1517
K66.8
ICD-10 Finland
Other specified disorders of peritoneum
+∞
38.7
37
*
N02AX02
ATC
tramadol; systemic, rectal
2.0
37.2
742
4845
6561
FHL
Removal of fasteners and related measures
31.5
37.1
49
16
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.9
36.0
104
186
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
6.4
34.2
92
150
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
32.4
518
3052
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.1
32.4
134
352
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.2
30.8
122
307
1410
FHL
Laparoscopy
4.7
28.8
102
230
6146A
ICD-9 Finland
Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female
8.9
28.4
61
71
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
28.2
161
547
A02BC05
ATC
esomeprazole; systemic
1.8
27.6
676
4587
N80.1
ICD-10 Finland
Endometriosis of ovary
5.3
26.9
84
165
N03AX16
ATC
pregabalin; oral
2.0
26.5
422
2443
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
2.6
26.5
212
890
K66.9
ICD-10 Finland
Disorder of peritoneum, unspecified
+∞
26.1
25
*
A06AD11
ATC
lactulose; oral
2.3
25.8
272
1318
JAL97
NOMESCO Finland
Other laparoscopic excision of lesion of peritoneum
264.7
25.8
26
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
25.2
458
2778
N80.9
ICD-10 Finland
Endometriosis, unspecified
7.7
24.7
58
78
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
23.9
314
1674
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
22.7
664
4674
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
22.6
427
2606
JAW97
NOMESCO Finland
Other laparoscopic operation on abdominal wall, peritoneum, mesentery or omentum
121.8
22.6
24
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
22.3
344
1948
8351
FHL
Removal of pelvic floor brackets
12.9
22.2
39
31
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
8.5
22.0
48
58
56901
ICD-8 Finland
Other diseases of intestines and peritoneum, Perforatio intestini NUD
+∞
21.9
21
*
P01AB01
ATC
metronidazole; oral, rectal
1.7
21.9
667
4734
45599
ICD-8 Finland
Haemorrhoids
4.4
21.7
81
193
A02BC01
ATC
omeprazole; systemic
1.8
21.7
464
2948
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
21.3
229
1111
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
20.9
440
2774
J01DA01
ATC
[U] cefalexin; systemic
1.7
20.7
988
7913
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.9
20.6
87
233
JFB00
NOMESCO Finland
Partial resection of small intestine
6.9
20.4
51
76
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.7
20.3
90
251
R51.80
ICD-10 Finland
Headache
2.1
20.3
250
1287
A02BA02
ATC
ranitidine; systemic
1.9
20.2
354
2095
SPAT1263
SPAT
Sampling
1.7
20.0
655
4708
56905
ICD-8 Finland
Other diseases of intestines and peritoneum, Fistula faecalis
+∞
19.8
19
*
K65.0
ICD-10 Finland
Acute peritonitis
202.4
19.6
20
*
A02BC03
ATC
lansoprazole; oral
1.7
19.1
491
3278
A03CA02
ATC
clidinium and psycholeptics; oral
2.7
18.8
131
505
R10.0
ICD-10 Finland
Acute abdomen
4.1
18.5
74
189
6202X
ICD-9 Finland
Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst
5.7
18.5
53
95
J01MA02
ATC
ciprofloxacin; systemic
1.7
18.5
604
4314
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.5
18.4
157
680
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
22.0
18.2
26
12
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
18.1
194
939
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.4
17.9
161
715
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
17.7
222
1150
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
7.9
17.6
40
52
61610
ICD-8 Finland
Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female
6.8
17.1
43
65
N06AA09
ATC
amitriptyline; systemic
2.1
17.1
199
998
8113
FHL
Fractional scraping
2.6
17.1
133
546
N05CF01
ATC
zopiclone; oral
1.7
17.0
517
3597
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
7.4
17.0
40
55
N02BE01
ATC
paracetamol; systemic, rectal
1.8
16.9
1319
11728
UKC02
NOMESCO Finland
Cystoscopy
2.0
16.8
247
1362
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
16.7
143
619
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
6.1
16.5
45
76
N03AX12
ATC
gabapentin; oral
1.9
16.5
254
1425
UJD02
NOMESCO Finland
Gastroscopy
2.9
16.4
101
361
J01MA12
ATC
levofloxacin; systemic
1.9
16.2
289
1706
H02AB06
ATC
prednisolone; systemic
1.6
16.1
709
5403
5608A
ICD-9 Finland
Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]
16.9
16.1
25
15
K59.0
ICD-10 Finland
Constipation
2.8
16.0
105
389
M79.6
ICD-10 Finland
Pain in limb
1.6
15.9
552
3963
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.4
15.8
41
65
B01AB05
ATC
enoxaparin; parenteral
1.6
15.8
470
3238
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
15.7
173
846
D01
ICPC
Abdominal pain/cramps general
2.2
15.6
169
820
JFK01
NOMESCO Finland
Laparoscopic division of adhesive band in intestinal obstruction
38.4
15.4
19
5
A03FA02
ATC
cisapride; oral, rectal
2.3
15.3
153
716
G03DC03
ATC
lynestrenol; oral
4.4
15.3
55
128
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
15.2
452
3110
N06AX16
ATC
venlafaxine; oral
2.0
15.2
224
1234
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
15.1
676
5147
JFW97
NOMESCO Finland
Other laparoscopic operation on intestine
45.4
15.1
18
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.2
15.0
164
797
N05BA04
ATC
oxazepam; oral
1.7
14.9
397
2649
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
14.8
212
1153
N80.81
ICD-10 Finland
Endometriosis in sacrouteral ligament
80.8
14.6
16
*
C07AB07
ATC
bisoprolol; oral
1.5
14.6
687
5283
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
14.5
147
690
G44.2
ICD-10 Finland
Tension-type headache
1.9
14.5
217
1202
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
14.4
94
349
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
14.4
435
2993
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
14.4
328
2087
J02AC01
ATC
fluconazole; systemic
1.5
14.3
644
4889
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
14.3
170
857
N83.1
ICD-10 Finland
Corpus luteum cyst
5.6
14.2
41
75
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
13.9
159
792
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
13.6
276
1691
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
13.6
271
1651
N80.0
ICD-10 Finland
Endometriosis of uterus
3.7
13.6
58
159
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
13.6
336
2187
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
13.3
593
4473
SPAT1153
SPAT
Removal of sutures
1.6
13.3
475
3402
R53
ICD-10 Finland
Malaise and fatigue
1.7
13.1
313
2012
K56.0
ICD-10 Finland
Paralytic ileus
8.4
13.0
28
34
8201
FHL
Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis
4.7
12.8
43
94
M01AE02
ATC
naproxen; oral, rectal
1.5
12.8
838
6846
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
12.5
443
3154
H02AB07
ATC
prednisone; oral
1.8
12.5
229
1356
56900
ICD-8 Finland
Other diseases of intestines and peritoneum, Abscessus intestini
+∞
12.5
12
*
N06AX11
ATC
mirtazapine; oral
1.5
12.3
464
3349
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.5
12.3
43
98
J01FA10
ATC
azithromycin; systemic
1.5
12.2
827
6776
M54.5
ICD-10 Finland
Low back pain
1.5
12.2
479
3490
D06
ICPC
Abdominal pain localized other
2.2
12.0
128
616
A02BC02
ATC
pantoprazole; systemic
1.5
12.0
969
8215
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
6.3
12.0
31
50
G04BD04
ATC
oxybutynin; oral, transdermal
2.4
12.0
100
429
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
3.1
12.0
66
221
M01AX17
ATC
nimesulide; oral
1.6
12.0
383
2658
R11
ICD-10 Finland
Nausea and vomiting
2.1
11.8
129
628
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
11.8
79
300
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.8
11.8
38
80
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
11.7
212
1248
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
11.7
169
921
SPAT1262
SPAT
Handing over of treatment supplies
1.7
11.7
263
1656
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
11.7
269
1706
R03BA05
ATC
fluticasone; inhalant
1.7
11.6
259
1631
8204
FHL
Salpingo-oophorectomy
4.7
11.5
38
82
XF402
NOMESCO Finland
ECG with work load test
1.9
11.5
173
953
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.7
11.5
50
140
M03BX02
ATC
tizanidine; oral
1.5
11.5
910
7654
56903
ICD-8 Finland
Other diseases of intestines and peritoneum, Periproctitis
+∞
11.5
11
*
5688X
ICD-9 Finland
Other disorders of peritoneum, Other specified disorders of peritoneum
+∞
11.5
11
*
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
11.4
575
4411
N06AX21
ATC
duloxetine; oral
1.9
11.3
171
947
AA1AD
NOMESCO Finland
CT of head and brain
1.6
11.2
332
2254
1413
FHL
Laparoscopy and other therapeutic procedure
2.9
11.2
69
246
JKA20
NOMESCO Finland
Cholecystectomy
3.2
11.0
57
183
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
11.0
171
955
6171A
ICD-9 Finland
Endometriosis of ovary
4.4
11.0
39
91
N02AA05
ATC
oxycodone; systemic
1.7
11.0
222
1352
R42
ICD-10 Finland
Dizziness and giddiness
1.6
11.0
329
2238
Y0599
ICD-8 Finland
Investigation of digestive system
4.0
10.9
42
106
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
10.9
188
1091
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
10.9
155
841
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
10.7
92
401
M79.1
ICD-10 Finland
Myalgia
1.8
10.7
188
1097
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
10.7
101
460
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
10.6
314
2128
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
11.3
10.6
19
17
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
3.4
10.5
49
146
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
10.5
317
2162
LCD00
NOMESCO Finland
Hysterectomy
2.3
10.5
97
437
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
10.5
107
505
JFK97
NOMESCO Finland
Other laparoscopic operation on adhesions in intestinal obstruction
110.7
10.4
11
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.5
10.4
48
142
S18
ICPC
Laceration/cut
1.4
10.4
580
4524
N05BA01
ATC
diazepam; systemic, rectal
1.7
10.4
210
1281
N06AB04
ATC
citalopram; systemic
1.6
10.4
331
2287
M25.5
ICD-10 Finland
Pain in joint
1.5
10.3
412
2994
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
10.3
372
2645
J01FF01
ATC
clindamycin; systemic
1.5
10.3
385
2759
N80.8
ICD-10 Finland
Other endometriosis
10.7
10.3
19
18
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.8
10.3
33
70
8307
FHL
Hysterectomy and unilateral removal of adhesions
5.1
10.2
31
62
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
10.2
235
1490
56096
ICD-8 Finland
Intestinal obstruction without mention of hernia, Ileus propter adhaesionem (functione laesa circulationis intestinalis non indicata)
13.2
10.2
17
13
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
10.2
510
3888
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
10.1
149
817
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.7
10.1
69
266
A03CA05
ATC
glycopyrronium bromide and psycholeptics; systemic
4.7
10.0
33
72
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.2
10.0
51
163
J01DB01
ATC
cefalexin; oral
1.5
10.0
1195
10734
R06.0
ICD-10 Finland
Dyspnoea
1.5
10.0
348
2451
R03AC02
ATC
salbutamol; inhalant
1.4
9.9
755
6222
R01AD08
ATC
fluticasone; nasal
1.5
9.9
410
2999
K56.7
ICD-10 Finland
Ileus, unspecified
4.3
9.9
35
82
6421
FHL
Appendicectomy
2.3
9.9
88
388
Y60
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
5.3
9.8
29
56
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
9.8
172
1004
C03CA01
ATC
furosemide; systemic
1.5
9.8
401
2927
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.5
9.8
33
74
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
9.7
220
1387
355
Kela drug reimbursment
Dienogest
55.3
9.7
11
*
JEA00
NOMESCO Finland
Appendectomy
2.2
9.6
94
434
WX110
NOMESCO Finland
Local anesthesy
1.4
9.6
963
8322
M01AH05
ATC
etoricoxib; oral
1.4
9.6
840
7084
N80.5
ICD-10 Finland
Endometriosis of intestine
15.1
9.5
15
10
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
9.5
712
5837
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.5
9.5
74
306
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.5
581
4592
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
9.4
128
681
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
9.4
208
1302
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
9.4
187
1134
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
+∞
9.4
9
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
9.3
121
631
M01AB05
ATC
diclofenac; systemic, rectal
1.4
9.3
974
8454
A02BC04
ATC
rabeprazole; oral
1.9
9.3
135
738
J01AA02
ATC
doxycycline; systemic
1.4
9.3
1178
10600
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
2.6
9.3
67
268
6266A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
2.7
9.2
62
237
6101
FHL
Exploratory laparotomy, includes possible biopases
13.7
9.2
15
11
N06AB03
ATC
fluoxetine; oral
1.7
9.2
191
1175
A03DA02
ATC
pitofenone and analgesics; systemic
3.2
9.1
47
152
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
3.5
9.1
41
120
JFB46
NOMESCO Finland
Resection of sigmoid colon
4.7
9.0
29
62
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
9.0
810
6826
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
9.0
286
1965
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
9.0
237
1558
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
3.6
8.9
38
106
J01FA06
ATC
roxithromycin; oral
1.4
8.8
598
4795
WX320
NOMESCO Finland
Spinalanesthesy
1.5
8.8
312
2203
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.6
278
1917
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.8
8.6
35
94
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
8.6
317
2250
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.7
8.6
28
61
JAD10
NOMESCO Finland
Repair of incisional hernia
5.8
8.6
23
40
A07EC02
ATC
mesalazine; oral, rectal
2.2
8.5
80
366
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
8.5
225
1477
G47.3
ICD-10 Finland
Sleep apnoea
1.6
8.5
264
1804
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.1
8.5
91
439
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.5
8.5
38
111
56899
ICD-8 Finland
Peritoneal adhesions
27.7
8.5
11
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
8.5
582
4671
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
8.4
189
1185
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
8.4
161
964
H02AB04
ATC
methylprednisolone; systemic
1.6
8.4
216
1406
K65.9
ICD-10 Finland
Peritonitis, unspecified
+∞
8.3
8
*
J01EA01
ATC
trimethoprim; systemic
1.4
8.3
399
2995
WX704
NOMESCO Finland
Intubation
2.0
8.2
104
539
R07.3
ICD-10 Finland
Other chest pain
1.8
8.2
137
789
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
8.1
160
971
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
9.0
8.0
16
18
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
2.8
8.0
51
189
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.6
8.0
34
96
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
3.1
7.9
41
134
N97.1
ICD-10 Finland
Female infertility of tubal origin
4.8
7.9
25
53
SPAT1283
SPAT
Restricted health certificate
1.6
7.9
198
1280
A02BA03
ATC
famotidine; systemic
2.3
7.9
68
299
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
7.9
181
1143
R52.2
ICD-10 Finland
Other chronic pain
2.6
7.9
55
216
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.7
7.9
160
975
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
7.9
56
223
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.5
7.9
61
253
L13
ICPC
Hip symptom/complaint
1.6
7.9
227
1522
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
7.8
112
611
A02BX02
ATC
sucralfate; oral
2.3
7.8
72
326
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
7.8
167
1032
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
2.9
7.8
46
164
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
7.8
268
1875
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.4
7.7
64
277
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
7.7
64
277
C10AC01
ATC
colestyramine; oral
2.8
7.7
49
181
A07AA02
ATC
nystatin; oral
2.0
7.7
95
491
SPAT1312
SPAT
General health counselling
1.4
7.7
429
3305
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
7.7
68
301
N03AE01
ATC
clonazepam; systemic
2.0
7.7
92
468
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
7.7
61
259
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.7
534
4277
R51
ICD-10 Finland
Headache
2.2
7.6
71
326
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
11.9
7.6
13
11
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
4.5
7.6
25
56
R02
ICPC
Shortness of breath/dyspnoea
1.7
7.5
163
1013
N70.0
ICD-10 Finland
Acute salpingitis and oophoritis
5.4
7.5
21
39
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
3.4
7.5
34
101
N05BA12
ATC
alprazolam; oral
1.7
7.5
153
935
M02AA07
ATC
piroxicam; topical
1.4
7.5
533
4279
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
1.9
7.5
107
582
G03DA04
ATC
progesterone; systemic, rectal, vaginal
2.3
7.5
67
300
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
7.5
77
368
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
7.4
271
1916
J01FA09
ATC
clarithromycin; systemic
1.4
7.4
447
3487
SPAT1260
SPAT
Consultation of another employee
1.5
7.4
249
1730
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
7.4
67
302
JFK96
NOMESCO Finland
Other operation on adhesions in intestinal obstruction
80.4
7.4
8
*
G03DB08
ATC
dienogest; oral
80.4
7.4
8
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
7.4
81
396
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
7.4
102
546
JF2AD
NOMESCO Finland
Colon CT
13.4
7.4
12
9
H01CA02
ATC
nafarelin; nasal
2.8
7.4
45
165
SPAT1301
SPAT
No procedures
1.4
7.4
433
3362
SPAT1255
SPAT
Intravenous administration of medicine
2.0
7.4
92
477
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
7.3
108
596
L03
ICPC
Low back symptom/complaint
1.5
7.3
326
2402
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.6
7.3
199
1317
N80
ICD-10 Finland
Endometriosis
9.4
7.3
14
15
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
7.2
233
1604
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
7.2
91
473
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
15.8
7.2
11
7
6402
FHL
Small bowel resection
15.8
7.2
11
7
6173A
ICD-9 Finland
Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]
4.3
7.2
25
59
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
7.2
397
3046
N05CD07
ATC
temazepam; oral
1.6
7.2
186
1213
6173B
ICD-9 Finland
Endometriosis of pelvic peritoneum[ENDOMETRIOSIS RETROUTERINA]
3.7
7.2
29
79
L04AX01
ATC
azathioprine; systemic
2.3
7.1
62
273
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
7.1
68
315
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.2
7.1
35
111
R52.9
ICD-10 Finland
Pain, unspecified
1.8
7.1
124
721
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.1
7.1
73
350
UJF92
NOMESCO Finland
Capsular endoscopy
3.5
7.1
31
90
D91
ICPC
Abdominal hernia other
4.6
7.1
23
51
O00.1
ICD-10 Finland
Tubal pregnancy
3.7
7.1
29
80
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
7.1
120
694
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.1
320
2364
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
7.0
65
298
LAC21
NOMESCO Finland
Laparoscopic destruction of lesion of ovary
4.7
7.0
22
47
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
7.0
103
566
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
7.0
185
1212
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.1
7.0
76
373
N97.8
ICD-10 Finland
Female infertility of other origin
3.8
7.0
27
71
LBE00
NOMESCO Finland
Salpingectomy
6.3
6.9
17
27
Z31.2
ICD-10 Finland
In vitrofertilization
6.3
6.9
17
27
E66.8
ICD-10 Finland
Other obesity
2.0
6.9
80
401
RF210
NOMESCO Finland
NA
2.8
6.9
42
154
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
6.9
377
2884
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
7.6
6.9
15
20
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.3
6.9
32
98
J46
ICD-10 Finland
Status asthmaticus
2.9
6.9
40
142
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.5
6.8
51
207
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
8.3
6.8
14
17
6201A
ICD-9 Finland
Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Corpus luteum cyst or haematoma
6.7
6.8
16
24
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
6.8
130
781
K92.9
ICD-10 Finland
Disease of digestive system, unspecified
9.3
6.8
13
14
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
6.8
105
590
R05FB02
ATC
cough suppressants and expectorants
1.3
6.8
548
4476
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
4.7
6.7
21
45
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
6.7
232
1623
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.7
6.7
135
823
JAB11
NOMESCO Finland
Laparoscopic repair of inguinal hernia
3.5
6.6
29
85
G03GA06
ATC
follitropin beta; parenteral
2.9
6.6
38
133
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
6.6
96
527
QBJ30
NOMESCO Finland
Correction of abdominal apron
4.6
6.6
21
46
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
6.6
107
610
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.6
6.6
193
1300
JFA70
NOMESCO Finland
Suture of small intestine
12.3
6.6
11
9
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
12.3
6.6
11
9
2200A
ICD-9 Finland
Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]
3.9
6.6
25
65
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
6.6
366
2806
SPAT1254
SPAT
Administration of medicine
1.6
6.5
191
1284
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
6.5
84
442
62620
ICD-8 Finland
Disorders of menstruation, Excessive
3.2
6.5
31
97
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
6.5
274
1994
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
6.5
531
4339
JF1BD
NOMESCO Finland
Very extensive small bowel CT
5.7
6.5
17
30
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.4
6.4
29
87
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.1
6.4
33
109
N05AA02
ATC
levomepromazine; systemic
2.2
6.4
61
284
Z54.0
ICD-10 Finland
Convalescence following surgery
3.5
6.4
28
82
N06AX05
ATC
trazodone; oral
2.7
6.4
42
161
JAA00
NOMESCO Finland
Incision of abdominal wall
14.4
6.4
10
7
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.4
452
3607
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.9
6.4
37
131
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.7
6.4
26
72
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
3.9
6.4
24
62
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.8
6.4
38
138
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.8
6.4
38
138
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
2.6
6.4
42
162
Z01.2
ICD-10 Finland
Dental examination
1.3
6.3
540
4433
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.3
221
1547
M01AH02
ATC
rofecoxib; oral
1.5
6.3
187
1263
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
5.5
6.3
17
31
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.9
6.3
92
508
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
6.3
92
508
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.7
6.3
25
68
N83.0
ICD-10 Finland
Follicular cyst of ovary
3.3
6.3
29
89
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
6.3
230
1627
5691A
ICD-9 Finland
Other disorders of intestine, Rectal prolapse
18.1
6.3
9
5
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
18.1
6.3
9
5
X58
ICD-10 Finland
Exposure to other specified factors
1.6
6.3
163
1067
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
26.8
6.2
8
*
R21
ICPC
Throat symptom/complaint
1.5
6.2
240
1717
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.5
6.2
47
194
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.9
6.2
89
489
K50.8
ICD-10 Finland
Other Crohn disease
3.5
6.1
26
75
SPAT1211
SPAT
Application of soft bandage
1.7
6.1
122
744
8117
FHL
Pertubatio
12.6
6.1
10
8
NBG10
NOMESCO Finland
Acromioplastia
2.5
6.0
43
172
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
4.4
6.0
20
46
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
2.6
6.0
41
162
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
10.1
6.0
11
11
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
6.0
52
230
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
2.4
6.0
46
191
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.8
6.0
35
125

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
709
4408
2.04
43.05
3.4
2.4
u/l
53.2
57.0
2.13
657
4053
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
982
7404
1.77
28.36
6.4
6.0
umol/l
10.3
11.0
1.12
932
7019
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
885
6605
1.71
25.33
4.7
4.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
300
1628
2.02
24.56
2.5
2.1
ug/g
161.9
126.2
0.72
234
1278
(3013826) Glucose [Moles/volume] in Serum or Plasma
1033
8113
1.69
23.78
5.3
4.5
mmol/l
6.7
6.7
0.12
972
7609
(3044640) Blood type and Crossmatch panel - Blood
645
4477
1.71
23.69
2.7
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
662
4715
1.66
21.52
5.5
5.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
815
6132
1.63
21.19
5.3
4.5
g/l
35.2
35.5
0.60
754
5691
(3031040) Bacteria [#/volume] in Urine by Automated count
1145
9380
1.67
21.12
6.0
4.6
e6/l
2440.9
2423.8
0.00
13
138
(3032080) INR in Blood by Coagulation assay
752
5567
1.63
20.74
9.2
9.0
inr
1.2
1.2
0.34
208
1587
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1284
10953
1.70
19.14
8.8
7.3
u/l
77.9
78.3
0.13
1216
10283
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
904
7092
1.58
18.92
7.0
6.2
mmol/l
1.2
1.2
0.47
746
5964
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
496
3386
1.66
18.41
2.7
2.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
180
899
2.12
18.18
2.8
3.3
u/ml
38.6
46.8
0.32
172
868
(3013512) EKG study
583
4167
1.61
17.87
4.8
3.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
312
1892
1.79
17.73
1.4
1.3
titre
573.3
546.2
0.08
75
414
(3022096) Basophils/100 leukocytes in Blood
818
6341
1.56
17.54
5.8
5.7
%
0.7
0.7
1.01
764
5897
(3019069) Monocytes/100 leukocytes in Blood
838
6555
1.55
17.09
6.4
6.0
%
8.3
8.5
1.19
785
6122
(3002030) Lymphocytes/100 leukocytes in Blood
854
6720
1.54
16.87
6.1
5.8
%
28.0
27.9
0.11
793
6242
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
824
6442
1.54
16.71
6.4
5.5
mmol/l
1.2
1.2
1.29
733
5811
(3006504) Eosinophils/100 leukocytes in Blood
833
6528
1.54
16.70
5.9
5.7
%
2.8
2.8
0.10
773
6065
(3019225) pH of Specimen
249
1435
1.86
16.64
3.5
3.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
585
4260
1.57
16.20
2.3
2.1
u/l
173.1
211.5
0.61
556
3997
(3018010) Neutrophils/100 leukocytes in Blood
839
6618
1.53
16.11
5.9
5.6
%
57.5
57.3
0.24
782
6174
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
702
5348
1.53
15.73
4.7
3.6
ng/l
27.9
45.4
1.56
503
3636
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
188
1007
1.97
15.62
1.6
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1081
9041
1.53
15.51
4.0
3.1
u/l
51.2
46.9
0.82
1008
8401
(3037467) Urinalysis macro (dipstick) panel - Urine
1148
9730
1.55
15.48
5.5
4.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1224
10535
1.57
15.31
5.0
4.1
mm/h
13.3
12.7
0.66
1124
9730
(3022145) Colonoscopy Study observation
261
1569
1.78
15.11
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
893
7207
1.50
14.93
6.0
5.8
e9/l
0.2
0.2
0.30
795
6320
(3001604) Monocytes [#/volume] in Blood
862
6916
1.50
14.77
5.6
5.6
e9/l
0.6
0.6
0.47
753
5971
(3006315) Basophils [#/volume] in Blood
865
6946
1.50
14.75
5.7
5.6
e9/l
0.0
0.0
1.17
761
6007
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
287
1790
1.73
14.58
5.0
4.5
%
32.5
32.8
0.15
198
1202
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
449
3139
1.58
14.55
2.1
1.6
mg/l
1.2
1.1
0.10
319
2401
(3019198) Lymphocytes [#/volume] in Blood
878
7098
1.49
14.31
5.7
5.6
e9/l
2.0
1.9
0.31
780
6252
(3013650) Neutrophils [#/volume] in Blood by Automated count
973
8146
1.45
12.52
8.2
8.9
e9/l
4.2
4.1
1.39
874
7137
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
367
2526
1.58
12.47
1.3
1.3
iu/ml
25.7
36.0
0.67
108
812
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
335
2261
1.60
12.36
1.8
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
216
1303
1.75
12.24
2.6
2.1
g/l
0.2
0.2
0.04
200
1213
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
285
1855
1.64
12.18
2.8
2.3
%
22.2
22.3
0.05
247
1570
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
489
3606
1.50
12.05
2.8
2.2
mg/l
3.0
3.0
0.13
416
3071
(3000570) Elastase.pancreatic [Mass/mass] in Stool
94
429
2.26
11.87
1.5
1.4
ug/g
262.2
293.5
0.81
59
246
(3003396) Base excess in Arterial blood by calculation
245
1547
1.68
11.75
5.7
7.3
mmol/l
1.2
1.3
0.05
176
1205
(3001122) Ferritin [Mass/volume] in Serum or Plasma
762
6146
1.43
11.68
3.5
2.7
ug/l
114.8
115.2
0.02
712
5671
(3023368) Bacteria identified in Blood by Culture
499
3716
1.48
11.65
4.6
4.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
299
1994
1.61
11.54
2.7
2.3
g/l
2.4
2.3
0.56
279
1838
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
750
6044
1.43
11.49
2.5
2.2
nmol/l
77.2
78.5
0.66
671
5407
(3019309) Folate [Moles/volume] in Red Blood Cells
382
2698
1.54
11.46
1.9
1.7
nmol/l
1080.1
1189.6
1.65
282
2023
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
589
4558
1.45
11.17
3.8
3.1
u/l
35.7
32.2
0.34
556
4329
(3000850) Epithelial cells [#/volume] in Urine
403
2899
1.51
11.05
3.2
2.5
e6/l
5.8
6.4
0.34
357
2543
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1251
11106
1.47
11.02
4.8
4.2
pmol/l
14.8
14.8
0.03
1136
10113
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
244
1575
1.64
10.70
2.9
2.5
umol/l
6.8
7.2
0.15
207
1365
(3016502) Oxygen saturation in Arterial blood
217
1363
1.68
10.57
5.9
7.7
%
95.9
95.6
0.26
200
1317
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
240
1548
1.64
10.55
5.8
7.3
kpa
5.1
5.1
0.47
221
1484
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
375
2684
1.51
10.47
4.2
3.7
ng/l
404.3
304.4
0.22
273
2069
(3022948) Iron [Moles/volume] in Serum or Plasma
315
2176
1.55
10.36
2.8
2.3
umol/l
13.2
12.8
0.38
297
2006
(3027801) Oxygen [Partial pressure] in Arterial blood
239
1549
1.63
10.30
5.8
7.3
kpa
12.2
12.3
0.05
222
1485
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
101
504
2.07
10.21
1.8
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
297
2034
1.56
10.13
1.4
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
242
1581
1.62
10.09
1.8
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
353
2.27
10.08
2.6
2.0
u/l
9361.0
2962.6
0.33
28
134
(3047181) Lactate [Moles/volume] in Blood
88
419
2.16
10.05
5.4
6.1
mmol/l
1.3
1.3
0.38
76
370
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
109
563
2.00
10.03
1.8
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
268
1807
1.57
9.77
22.1
24.2
inr
1.4
1.3
0.52
45
244
(3026493) Urate [Moles/volume] in Serum or Plasma
474
3610
1.43
9.50
2.6
2.5
umol/l
1081.7
6197.5
5.36
405
3096
(3002173) Hemoglobin [Mass/volume] in Arterial blood
200
1264
1.66
9.49
6.2
8.0
g/l
121.1
120.3
0.25
188
1221
(3008152) Bicarbonate [Moles/volume] in Arterial blood
145
845
1.78
9.22
6.3
6.4
mmol/l
24.4
24.6
0.26
131
791
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
411
3067
1.45
9.15
1.3
1.2
u/ml
1.4
1.5
0.06
97
796
(3036481) Cortisol [Moles/volume] in Serum or Plasma
204
1313
1.63
9.00
2.1
2.0
nmol/l
364.7
373.9
0.28
181
1196
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
338
2442
1.48
8.87
1.4
1.3
u/ml
3.8
12.3
4.54
117
934
(3003458) Phosphate [Moles/volume] in Serum or Plasma
260
1778
1.55
8.86
6.2
4.7
mmol/l
1.1
1.0
1.38
248
1632
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
125
708
1.83
8.74
7.1
10.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
315
2251
1.49
8.71
3.2
3.0
mmol/l
0.8
0.8
0.72
291
2099
(3002582) Erythrocytes [#/volume] in Urine
526
4148
1.39
8.46
4.1
3.2
e6/l
56.0
88.5
0.48
435
3174
(3025941) Bacteria identified in Stool by Culture
130
760
1.77
8.19
1.4
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
148
899
1.71
8.15
4.5
4.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
565
4543
1.36
7.96
3.5
3.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
397
3028
1.41
7.66
1.8
1.7
pmol/l
25610191.6
29237383.6
0.05
328
2490
(3002256) Pathology report gross observation
261
1840
1.49
7.66
1.3
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
354
2669
1.41
7.26
1.4
1.4
g/l
2.3
2.4
0.45
217
1598
(3015171) Extractable nuclear Ab [Units/volume] in Serum
100
561
1.83
7.25
1.4
1.3
u/ml
0.2
1.5
1.49
12
48
(3042936) Bacteria identified in Isolate by Culture
273
1965
1.46
7.20
2.1
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
700
5897
1.32
6.95
2.1
2.0
pmol/l
94.9
95.5
0.10
357
2985
(3026389) Candida sp identified in Specimen by Organism specific culture
44
186
2.40
6.73
1.5
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
176
1172
1.56
6.72
2.9
2.9
ng/l
174.2
201.5
0.50
161
1072
(3018095) Leukocytes [#/volume] in Urine
594
4908
1.32
6.71
4.6
3.7
e6/l
90.8
113.4
0.40
464
3427
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
78
3.24
6.71
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
215
1497
1.50
6.68
3.3
4.2
ug/l
34.2
16.9
0.26
164
1226
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1401
13064
1.41
6.63
5.9
5.0
mu/l
1.8
2.1
1.05
1280
11934
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1483
13976
1.47
6.58
20.4
14.0
mg/l
22.4
23.1
0.37
1297
11083
(3017181) Myelocytes/100 leukocytes in Blood
176
1179
1.55
6.54
3.4
3.9
%
1.0
0.9
0.19
43
337
(3039000) Anion gap in Blood
61
302
2.06
6.40
6.2
6.8
mmol/l
11.3
11.1
0.18
54
276
(3018572) Chloride [Moles/volume] in Blood
61
302
2.06
6.40
6.2
6.8
mmol/l
104.9
105.3
0.33
54
276
(3009343) pH of Capillary blood
131
824
1.64
6.35
3.0
3.4
ph
7.4
7.4
1.41
11
102
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
132
832
1.64
6.34
3.1
3.4
kpa
5.3
5.2
0.79
123
778
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
128
801
1.65
6.33
1.5
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
107
639
1.72
6.30
2.0
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
354
2728
1.38
6.30
3.5
2.7
mosm/kgh2o
507.2
538.1
2.06
310
2312
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
500
4064
1.33
6.26
3.1
2.9
ng/l
1296.3
1315.8
0.04
418
3433
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
95
551
1.77
6.20
5.4
5.0
%
1.6
1.5
0.57
88
522
(3015377) Calcium [Moles/volume] in Serum or Plasma
595
4961
1.31
6.18
2.9
3.4
mmol/l
2.3
2.4
1.29
514
4343
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
77
3.15
6.17
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
20
57
3.54
6.16
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
20
57
3.54
6.16
1.3
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
69
367
1.92
5.94
3.7
2.2
%
193.5
182.1
0.44
63
353
(3045424) Erythrocytes [Presence] in Urine
48
226
2.16
5.76
1.7
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
206
1467
1.46
5.71
4.5
3.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
103
627
1.68
5.68
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
164
1120
1.51
5.59
3.5
4.0
%
0.1
0.1
0.96
38
308
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
123
788
1.60
5.56
2.9
3.4
mmol/l
1.9
1.9
0.08
93
597
(3005322) IgE [Units/volume] in Serum or Plasma
135
887
1.57
5.49
1.3
1.2
u/ml
142.4
193.7
0.65
122
809
(3007930) Methemoglobin/Hemoglobin.total in Blood
92
549
1.71
5.47
5.5
5.0
%
0.9
0.9
0.22
85
519
(36304419) Bacteria [Presence] in Urine
453
3694
1.31
5.42
4.0
3.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
143
955
1.54
5.41
4.0
2.9
e9/l
4.2
4.1
0.38
108
739
(3000991) Gas panel - Venous blood
156
1067
1.51
5.29
6.9
8.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
163
1127
1.49
5.25
4.6
3.4
ng/l
93.2
84.4
0.62
138
975
(3004616) Nuclear Ab [Presence] in Serum
38
171
2.25
5.12
1.3
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
166
1159
1.48
5.10
5.6
7.1
mmol/l
1.4
1.3
0.19
160
1110
(3002179) Metamyelocytes/100 leukocytes in Blood
156
1076
1.50
5.09
3.5
3.7
%
0.8
0.6
0.53
33
243
(3036489) Thrombin time
84
500
1.72
5.06
2.4
1.9
s
21.2
21.2
0.06
70
438
(3030467) Casts [#/volume] in Urine by Automated count
461
3802
1.29
5.01
4.2
3.1
e6/l
0.3
0.5
1.25
371
2857
(3025159) Blasts/100 leukocytes in Blood
152
1050
1.49
4.92
3.5
4.0
%
0.0
0.7
0.94
31
254
(3022313) Gas panel - Capillary blood
97
606
1.64
4.88
2.9
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
445
3664
1.29
4.88
4.9
4.1
estimate
0.0
0.0
0.88
159
1226
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
134
904
1.52
4.86
3.4
3.2
pmol/l
4.5
4.5
0.10
110
795
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
163
1145
1.47
4.86
2.4
2.4
ug/l
5.2
6.8
0.67
133
1003
(3020779) Urea [Moles/volume] in Serum or Plasma
160
1122
1.47
4.81
9.1
6.3
mmol/l
10.1
9.7
0.29
153
1068
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
69
394
1.78
4.81
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
11
24
4.61
4.78
1.2
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
270
2080
1.35
4.74
2.2
1.9
s
29.5
29.6
0.14
257
2007
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
182
1312
1.43
4.74
3.4
2.1
u/l
39.2
37.1
0.09
158
1124
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
67
382
1.78
4.70
1.2
1.2
u/ml
2.1
9.2
—
7
72
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
76
452
1.71
4.62
1.3
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
506
4267
1.26
4.53
3.2
3.1
mmol/l
7.1
7.1
0.00
421
3574
(3037121) Protein [Mass/volume] in Urine
77
463
1.69
4.50
2.5
3.0
g/l
0.2
0.3
0.17
26
172
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
293
2311
1.32
4.38
1.6
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
121
825
1.50
4.21
1.7
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
781
6957
1.23
4.15
4.8
3.8
estimate
0.0
0.0
0.05
161
1231
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
54
301
1.82
4.12
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
673
5911
1.23
4.08
2.3
2.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
506
4310
1.25
4.08
3.9
3.9
mg/mmol
10.0
8.6
0.27
299
2624
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
223
1.95
4.08
1.1
1.1
u/ml
0.7
1.6
0.80
15
91
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
36
175
2.08
4.07
1.4
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
18
63
2.88
4.06
1.1
1.0
u/ml
0.2
1.4
—
6
20
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
134
940
1.46
4.05
1.9
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
769
6851
1.22
4.05
4.7
3.7
estimate
0.0
0.0
0.00
160
1252
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
64
379
1.72
3.99
1.1
1.1
u/ml
1.1
4.6
—
7
44
(3021601) Nitrite [Presence] in Urine by Test strip
772
6888
1.22
3.99
6.4
5.1
estimate
0.0
0.0
0.50
163
1258
(3005719) IgG [Mass/volume] in Serum or Plasma
142
1011
1.44
3.98
2.3
2.8
g/l
10.3
10.5
0.29
129
919
(3017143) Hepatitis C virus Ab [Presence] in Serum
176
1307
1.39
3.89
1.7
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
172
2.06
3.86
1.4
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
85
547
1.58
3.85
2.1
2.0
ug/l
2.2
1.7
0.13
72
481
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
409
1.66
3.75
1.6
1.6
iu/ml
0.2
14.5
0.49
13
83
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
174
2.03
3.75
1.4
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
208
1597
1.34
3.73
1.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
442
3742
1.24
3.72
4.6
3.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
182
2.00
3.69
1.8
2.5
mg/l
46.0
28.7
—
5
52
(3003338) MCHC [Mass/volume]
1088
11635
0.82
3.68
25.1
18.4
g/l
330.8
331.5
1.49
1082
11546
(3019150) Specific gravity of Urine by Refractometry
359
2976
1.26
3.62
4.8
4.2
kg/l
1.0
1.0
0.00
72
441
(3012516) Albumin [Mass/volume] in Urine
477
4083
1.23
3.61
3.3
3.2
mg/l
383.7
389.8
0.01
282
2483
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
103
703
1.50
3.60
1.1
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
58
345
1.71
3.59
1.3
1.1
titre
76.0
80.4
—
5
24
(4146454)
32
157
2.06
3.57
3.0
2.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
45
249
1.83
3.55
1.2
1.3
mmol/l
62.0
61.4
0.04
34
197
(3025468) Yersinia sp identified in Specimen by Organism specific culture
34
171
2.01
3.55
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
34
171
2.01
3.55
1.4
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
34
171
2.01
3.55
1.4
1.6
%
57.3
58.2
0.04
18
110
(3023511) Choriogonadotropin [Units/volume] in Urine
38
199
1.93
3.54
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
30
144
2.10
3.54
3.0
4.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
67
418
1.63
3.47
3.9
3.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
34
173
1.98
3.45
1.4
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1500
14449
1.32
3.38
22.0
16.1
mmol/l
139.5
139.7
1.90
1471
14064
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
204
1586
1.33
3.37
1.7
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
46
261
1.78
3.37
2.2
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
362
3028
1.25
3.36
4.4
4.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
10
27
3.72
3.35
4.0
4.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
102
706
1.47
3.35
6.6
9.8
mmol/l
24.4
24.5
0.02
93
661
(3028026) IgM [Mass/volume] in Serum or Plasma
113
798
1.45
3.34
1.7
1.7
g/l
1.2
1.5
1.28
106
729
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
83
2.43
3.31
1.5
1.6
u/l
4.2
8.9
0.93
12
41
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
90
609
1.50
3.30
4.3
3.5
mmol/l
24.9
24.3
0.98
83
548
(40761536) Microorganisms panel - Urine sediment
157
1178
1.37
3.29
5.5
3.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
78
514
1.54
3.24
3.6
3.3
u/ml
89.5
2798.8
0.79
66
444
(3038026) Centromere Ab [Units/volume] in Serum
25
117
2.15
3.17
1.2
1.1
—
72.9
—
0
7
(3033658) Prothrombin time (PT) actual/Normal
412
3518
1.23
3.15
5.2
3.7
%
92.4
91.4
0.32
403
3419
(3023103) Potassium [Moles/volume] in Serum or Plasma
1501
14485
1.30
3.14
22.2
16.2
mmol/l
4.0
4.0
0.17
1471
14077
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
44
2.97
3.13
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
37
201
1.86
3.13
1.2
1.4
u/l
30.1
30.7
0.03
30
165
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
28
138
2.05
3.12
1.1
1.2
u/l
52.2
53.8
0.07
18
97
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
142
1058
1.37
3.11
2.0
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
147
1103
1.36
3.09
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
394
3356
1.23
3.08
1.7
1.5
nmol/l
21.0
21.3
0.15
325
2851
(3022806) Fractional oxyhemoglobin in Capillary blood
32
167
1.93
3.05
2.2
1.8
%
88.8
89.7
0.40
32
167
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
378
1.61
3.03
1.7
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
49
293
1.69
3.02
5.1
4.3
mmol/l
2.4
2.8
0.50
34
206
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
208
1648
1.30
3.01
1.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
49
294
1.69
2.99
1.4
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
39
219
1.80
2.99
1.4
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
64
412
1.57
2.96
1.8
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
193
1518
1.31
2.95
3.8
3.9
u/l
242.4
252.2
0.34
181
1434
(4010399)
133
991
1.37
2.93
1.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
49
296
1.67
2.92
1.4
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
17
4.72
2.92
1.4
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
17
4.72
2.92
10.5
12.7
mmol/l
7.0
5.7
—
8
17
(1616796) Gas panel - Central venous blood
47
281
1.69
2.91
3.4
3.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
24
115
2.10
2.89
1.2
1.1
—
38.6
—
0
5
(3004588) Protein electrophoresis panel - Serum or Plasma
129
959
1.37
2.88
1.5
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
913
8429
1.18
2.88
3.0
2.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
91
636
1.46
2.88
1.1
1.1
titre
—
223.0
—
0
12
(3023520) Reticulocytes [#/volume] in Blood
152
1160
1.34
2.88
2.0
2.5
e9/l
70.9
70.9
0.01
116
886
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
56
353
1.61
2.84
1.4
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
24
116
2.08
2.83
1.2
1.1
—
82.5
—
0
11
(3020891) Body temperature
76
515
1.50
2.81
5.8
4.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
202
1.80
2.78
1.0
1.0
u/ml
4.2
4.6
0.06
15
95
(3000764) Benzodiazepines [Presence] in Urine
48
293
1.66
2.77
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
106
769
1.40
2.75
2.2
2.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
14
5.02
2.73
1.0
1.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
13
48
2.72
2.72
6.6
3.6
mg/l
62.8
73.9
—
8
33
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
262
2168
1.25
2.67
3.5
2.9
e6/l
4.6
2.8
1.50
154
1165
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
128
964
1.35
2.66
2.6
2.5
au/ml
31.0
21.7
—
9
52
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
73
2.34
2.65
1.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
49
2.67
2.62
2.3
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
154
1196
1.32
2.60
4.8
3.4
mmol/l
2.5
2.0
0.74
132
968
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
591
5298
1.18
2.59
5.2
4.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
155
1206
1.31
2.59
4.8
3.4
kpa
6.0
5.8
0.91
149
1169
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
85
600
1.44
2.58
1.8
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
38
2.91
2.58
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
127
961
1.35
2.57
3.3
3.2
—
—
—
0
0
(4094501)
57
371
1.55
2.56
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
11
5.47
2.54
1.2
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
32
179
1.80
2.52
2.5
2.0
u/ml
159.2
26.2
0.40
32
172
(3020630) Protein [Mass/volume] in Serum or Plasma
146
1131
1.32
2.52
1.8
2.7
g/l
66.4
66.5
0.06
126
1025
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
34
194
1.77
2.51
1.6
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
129
1.95
2.51
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
56
365
1.55
2.50
5.1
3.9
ph
7.4
7.4
0.10
46
289
(3024980) IgG subclass 4 [Mass/volume] in Serum
36
210
1.73
2.47
1.4
1.6
g/l
0.5
0.8
2.01
30
159
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
16
4.39
2.47
1.4
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
21
3.82
2.46
1.0
1.3
ng/l
95.9
92.0
—
8
21
(3027945) Reticulocytes/100 erythrocytes in Blood
193
1557
1.27
2.45
2.1
2.4
%
1.8
1.8
0.31
174
1385
(3016879) Cocaine [Presence] in Urine
44
272
1.63
2.45
1.4
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
42
257
1.65
2.43
1.4
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
46
289
1.61
2.41
1.3
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
161
0.31
2.41
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
48
305
1.59
2.40
1.2
1.3
mmol/l
3.6
3.8
1.78
43
286
(3049717) Cytology report of Urine Cyto stain
71
492
1.46
2.39
2.4
2.7
—
—
—
0
0
(3004451) EKG impression Narrative
15
64
2.36
2.39
2.3
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
97
2.07
2.37
1.4
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
71
2.27
2.34
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
38
229
1.67
2.34
5.2
5.2
iu/ml
360.5
269.5
—
6
29
(3030905) Polymorphonuclear cells [#/volume] in Blood
44
276
1.61
2.33
2.8
3.4
e9/l
4.2
4.3
0.06
44
276
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
10
35
2.87
2.30
1.1
1.2
%
—
14.0
—
0
6
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
130
1006
1.32
2.28
1.1
1.2
iu/ml
133.5
141.5
0.07
50
388
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
92
2.08
2.27
1.2
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
25
134
1.88
2.27
2.9
3.0
%
57.2
56.0
0.09
11
90
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
45
286
1.59
2.26
3.2
3.6
%
59.7
58.5
0.31
45
286
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
114
869
1.33
2.23
1.4
1.3
au/ml
26.5
45.7
—
7
44
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
14
60
2.34
2.22
1.0
1.1
%
115.7
92.7
2.08
14
51
(3018418) pH of Serum or Plasma
477
4252
1.17
2.19
4.9
3.7
ph
7.4
7.4
0.18
93
799
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
80
2.14
2.19
1.1
1.1
ratio
1.1
1.1
—
9
33
(3000494) Fungus identified in Specimen by Culture
198
1627
1.25
2.17
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
74
2.17
2.15
1.5
1.4
nmol/l
154.5
139.4
0.27
16
74
(4211845)
15
68
2.22
2.11
2.2
3.7
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
12
49
2.46
2.10
1.3
1.6
pmol/l
12.4
14.6
—
7
40
(3044290) Cell count panel - Cerebral spinal fluid
42
268
1.58
2.10
1.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
198
1.68
2.09
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
10
5.01
2.07
4.2
5.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
109
837
1.32
2.04
1.5
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
29
169
1.73
2.04
1.3
1.3
nmol/l
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
85
1133
0.74
2.03
1.4
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
26
147
1.78
2.03
1.4
1.3
mosm/kgh2o
269.8
276.3
0.72
19
103
(3032057) Clostridioides difficile [Presence] in Stool
9
32
2.82
2.00
2.0
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
513
1.40
1.96
1.5
2.4
g/l
3.0
3.1
0.42
47
404
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
64
2.20
1.94
2.6
2.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
23
127
1.82
1.94
1.5
1.9
—
—
—
0
0
(3019977) pH of Arterial blood
15
71
2.12
1.92
2.1
3.3
ph
7.5
7.4
—
5
21
(3014271) Vancomycin [Susceptibility]
15
71
2.12
1.92
4.1
2.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
113
1.87
1.92
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1337
12902
1.17
1.90
6.5
5.7
mmol/mol
40.1
39.8
0.55
1221
11911
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
92
1.97
1.90
1.4
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
23
128
1.81
1.90
2.3
3.0
mg/l
159.5
22.2
0.47
17
92
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
65
466
1.41
1.89
1.7
1.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
22
3.19
1.88
1.1
1.1
%
103.0
96.4
—
7
22
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
22
3.19
1.88
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1102
11524
0.88
1.85
24.0
17.2
%
13.9
13.7
1.69
1094
11271
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
29
175
1.67
1.83
1.4
1.4
pmol/l
255.0
298.7
0.55
22
132
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
607
1.35
1.82
1.6
1.8
g/l
1.4
1.5
0.76
72
535
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
94
1.92
1.80
1.4
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
215
1.59
1.80
1.7
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
23
3.05
1.80
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
345
1.46
1.79
2.3
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
73
540
1.37
1.78
1.6
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
33
208
1.60
1.77
1.4
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
542
1.36
1.75
1.6
2.4
g/l
3.8
3.7
0.11
47
395
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
18
3.34
1.74
1.8
2.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
63
457
1.39
1.73
2.3
2.2
ug/l
405.3
496.6
0.25
57
427
(3048929) Epstein Barr virus Ab [Presence] in Serum
48
331
1.46
1.73
1.1
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
543
1.36
1.73
1.6
2.4
g/l
7.9
7.5
0.82
49
410
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
543
1.36
1.73
1.6
2.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
30
2.67
1.72
1.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
41
274
1.51
1.72
3.2
2.9
umol/l
33.5
35.5
0.23
36
230
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
24
2.92
1.72
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
194
1.61
1.72
1.0
1.1
u/ml
0.3
1.4
—
7
81
(4306422)
32
202
1.60
1.72
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
61
2.14
1.71
2.3
4.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
68
2.07
1.70
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
59
425
1.40
1.69
2.8
2.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
55
2.19
1.67
1.3
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
19
3.17
1.66
1.8
2.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
13
62
2.11
1.65
1.2
1.5
%
—
58.9
—
0
10
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
172
1439
1.22
1.63
1.7
1.7
%
1.5
1.4
0.54
150
1246
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
205
1.57
1.63
1.2
1.2
u/ml
265.5
262.0
0.02
23
115
(3008898) HLA-B27 [Presence]
63
463
1.37
1.62
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
143
1.69
1.61
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1404
13647
1.16
1.61
5.1
4.6
mmol/l
5.9
5.9
0.48
1269
12404
(3024932) HLA-DR beta [Type]
8
32
2.51
1.59
1.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
32
2.51
1.59
1.6
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
46
321
1.45
1.58
1.6
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
121
1.74
1.58
1.1
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
20
3.01
1.58
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
34
223
1.54
1.57
2.9
3.3
%
0.7
1.5
1.65
21
178
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
184
1.59
1.54
1.0
1.0
u/ml
2.0
1.1
—
6
39
(3051611) Lipemic interference index of Serum or Plasma
24
145
1.66
1.54
5.0
3.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
33
2.43
1.54
1.0
1.0
—
—
—
0
0
(44813793)
18
100
1.81
1.53
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
41
282
1.47
1.53
2.1
2.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
241
1.50
1.53
1.6
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
115
1.75
1.52
1.1
1.2
u/ml
0.1
0.7
—
10
49
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
76
583
1.32
1.50
1.7
2.0
u/l
40.7
39.3
0.23
69
513
(3000475) Leukocytes [#/volume] in Synovial fluid
48
342
1.42
1.49
1.6
1.7
e6/l
19878.9
13348.1
0.29
36
249
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
265
2325
1.17
1.49
3.3
2.7
e6/l
1.3
1.2
0.19
158
1317
(3009466) Valproate [Moles/volume] in Serum or Plasma
31
202
1.54
1.49
4.3
5.2
umol/l
347.5
360.2
0.21
23
176
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
56
411
1.37
1.48
2.2
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
21
124
1.70
1.47
1.3
1.5
%
32.4
34.4
—
9
78
(40767503) Oxygen content in Capillary blood by calculation
39
268
1.47
1.47
3.4
2.3
%
15.9
16.2
0.12
15
133
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
58
429
1.36
1.46
1.6
2.2
g/l
37.6
37.5
0.05
43
370
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
187
1.56
1.46
1.6
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
29
187
1.56
1.46
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
344
1.41
1.45
1.2
1.1
—
—
—
0
0
(4015189)
9
38
2.38
1.45
1.3
2.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
508
1.33
1.44
1.6
2.4
g/l
10.1
10.2
0.07
48
430
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
16
3.13
1.44
1.0
1.1
u/l
34.2
28.6
—
5
11
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
212
1.52
1.43
1.6
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
59
2.04
1.43
1.1
1.9
ug/l
15.8
154.2
0.50
12
51
(40758558) Short blood count panel - Blood
400
3624
1.14
1.43
6.5
6.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
122
1003
1.23
1.40
4.1
2.7
kpa
4.6
4.5
0.23
117
968
(4198724)
7
29
2.42
1.39
1.9
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
46
331
1.40
1.38
3.4
2.8
mmol/l
25.4
25.1
0.21
38
288
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
89
1.81
1.37
2.6
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
57
426
1.35
1.36
4.2
2.7
u/ml
0.3
0.4
0.20
35
238
(3013139) Helicobacter pylori Ag [Presence] in Stool
115
946
1.23
1.33
1.3
1.2
—
—
—
0
0
(4024509)
23
144
1.61
1.32
1.8
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
201
1.50
1.30
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
18
2.78
1.28
1.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
19
114
1.67
1.28
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
210
1.49
1.28
1.2
1.2
u/ml
2.3
2.2
—
10
61
(3037556) Urate [Mass/volume] in Serum or Plasma
10
48
2.09
1.27
1.1
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
15
84
1.79
1.27
1.9
2.1
e6/l
837.7
776.0
—
7
36
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
154
1.57
1.26
1.0
1.0
u/ml
5.3
2.5
—
9
52
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
77
1.82
1.25
2.0
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
29
195
1.50
1.24
1.6
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
364
1.36
1.24
1.3
1.3
miu/ml
188.1
224.7
0.37
18
170
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
93
1.73
1.21
1.9
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
78
1.80
1.21
2.0
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
78
1.80
1.21
1.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
41
297
1.39
1.21
1.2
1.5
e6/l
1.7
35.9
1.23
26
231
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
41
297
1.39
1.21
1.2
1.5
e6/l
29.5
1898.9
1.31
29
244
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
124
1.62
1.21
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
222
1956
1.16
1.20
1.8
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
230
1.44
1.20
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
135
1143
1.20
1.19
3.9
3.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
186
0.53
1.17
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1357
13239
1.12
1.15
17.6
13.0
ml/min/173m2
79.4
79.6
0.10
1179
10970
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
39
2.06
1.15
1.1
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
302
2727
1.13
1.15
2.9
3.0
mmol/l
2.5
2.5
0.05
266
2409
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
327
1.35
1.13
1.5
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
30
2.34
1.12
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
119
1.60
1.11
1.1
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
22
143
1.55
1.11
1.2
1.4
—
30.9
—
0
8
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
143
1.55
1.11
1.0
1.0
u/ml
1.5
3.3
—
9
51
(3016018) Differential panel - Cerebral spinal fluid
20
127
1.58
1.11
1.2
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
198
1742
1.15
1.11
6.9
7.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
31
2.26
1.10
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
47
355
1.33
1.09
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
104
1.64
1.09
2.3
1.8
%
10.4
10.5
0.02
17
104
(3044927) Protein electrophoresis panel - Urine
23
152
1.52
1.09
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
147
1267
1.18
1.08
1.6
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
29
202
1.44
1.08
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
219
1.42
1.07
1.2
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
180
0.55
1.07
1.4
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
33
2.13
1.05
2.9
3.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
179
0.56
1.05
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
195
1.44
1.04
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
565
0.75
1.04
1.6
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
154
1.50
1.04
1.8
1.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
16
98
1.64
1.03
1.3
1.4
—
65.3
—
0
7
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
44
333
1.33
1.02
1.6
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
83
1.69
1.01
5.0
3.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
152
1740
0.86
1.00
3.1
3.1
ug/l
0.7
0.8
1.35
109
1177
(3024869) Neuronal Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
187
0.59
0.97
1.5
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
36
1.95
0.97
2.1
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
36
1.95
0.97
2.7
2.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
100
1.61
0.96
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
100
1.61
0.96
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
100
1.61
0.96
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
51
1.77
0.94
3.6
4.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
101
1.59
0.93
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
101
1.59
0.93
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
101
1.59
0.93
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
31
226
1.38
0.92
1.5
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
22
315
0.69
0.92
2.0
4.0
u/ml
19.5
33.6
1.00
22
307
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
10
55
1.82
0.92
2.5
2.1
umol/l
47.1
50.9
—
10
41
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
28
2.15
0.91
1.2
1.1
—
6.7
—
0
5
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
58
465
1.26
0.90
1.6
2.5
g/l
0.8
1.1
0.29
45
404
(3011412) CD3 cells [#/volume] in Blood
17
110
1.55
0.90
2.0
2.0
e9/l
1.3
1.2
—
8
63
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
42
1.91
0.88
3.0
2.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
289
1.32
0.88
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
289
1.32
0.88
1.5
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
136
1188
1.16
0.87
4.5
3.5
mmol/l
1.2
1.2
0.27
115
1020
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
44
1.82
0.86
3.0
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
49
388
1.27
0.85
1.6
2.0
iu/l
3.5
5.0
0.60
14
139
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
188
1.39
0.83
1.7
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
81
1.61
0.81
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
47
1.71
0.80
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
49
393
1.25
0.79
1.2
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
174
1.38
0.77
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1351
13261
1.09
0.76
4.5
4.0
mmol/l
1.4
1.3
7.96
1240
12084
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
28
209
1.35
0.76
1.2
1.2
u/ml
3.8
5.5
—
9
79
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
288
1.29
0.75
2.8
2.1
g/l
124.9
129.3
0.61
22
209
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
91
1.54
0.75
1.9
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
67
1.65
0.75
1.1
1.0
—
—
—
0
0
(4035726)
141
1252
1.14
0.75
1.4
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
83
1.57
0.75
1.3
1.9
%
8.5
13.4
—
6
35
(1175426) CD3 cells/100 lymphocytes in Blood
13
84
1.55
0.72
1.5
2.0
%
78.3
71.9
1.32
13
79
(4281824)
24
177
1.36
0.71
1.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
26
1.93
0.70
1.0
1.7
mmol/l
1.2
1.2
—
5
26
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
18
126
1.43
0.70
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
41
1.71
0.70
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
61
1.64
0.68
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
61
1.64
0.68
1.1
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
69
1.60
0.68
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
344
3223
1.08
0.67
4.2
3.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
642
6158
1.07
0.66
12.0
9.2
e9/l
0.0
0.0
0.34
546
5050
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
28
1.79
0.66
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
237
0.71
0.66
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
259
1.28
0.65
1.9
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
171
1.35
0.65
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
166
1504
1.11
0.65
1.6
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
394
0.78
0.65
1.4
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
70
1.58
0.65
1.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
70
1.58
0.65
1.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
70
1.58
0.65
1.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
70
1.58
0.65
1.1
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
49
404
1.22
0.65
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
178
0.67
0.65
3.2
2.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
120
1.42
0.64
2.1
2.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
128
0.62
0.64
1.1
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
190
1.32
0.63
2.0
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
86
749
1.16
0.62
3.6
3.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
49
1.64
0.62
2.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
30
235
1.28
0.61
3.1
2.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
182
1.32
0.61
1.3
1.3
mmol/l
7.6
7.5
0.04
19
130
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
80
1.50
0.59
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
148
1.36
0.59
1.9
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
151
0.66
0.59
1.8
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
25
192
1.31
0.59
1.0
1.0
u/ml
1.4
1.9
—
9
83
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
185
0.70
0.58
1.4
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
319
1.23
0.57
1.6
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
132
1.37
0.57
1.4
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
461
4827
0.94
0.56
2.9
2.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
37
1.62
0.55
1.3
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
37
1.62
0.55
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
37
1.62
0.55
1.5
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
60
1.50
0.54
2.9
2.7
u/ml
363.7
1186.5
—
9
60
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
61
1.48
0.53
1.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
108
1.39
0.53
2.0
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
18
134
1.35
0.53
4.9
4.9
u/ml
45.6
46.1
—
8
39
(3044007) Cell count panel - Peritoneal fluid
6
39
1.54
0.53
1.2
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
62
1.45
0.53
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
67
767
0.87
0.52
1.4
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
40
1.50
0.51
1.3
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
22
170
1.30
0.51
6.2
6.1
mg/l
11.6
12.0
0.16
22
155
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
64
1.41
0.51
1.1
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
24
188
1.28
0.51
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
92
1.42
0.50
1.2
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
41
1.47
0.50
1.7
2.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
41
1.47
0.50
4.5
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
41
1.47
0.50
1.7
2.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
189
1.27
0.49
1.0
1.1
—
—
—
0
0
(4062490)
18
136
1.33
0.49
1.5
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
45
1.56
0.49
1.6
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
234
0.77
0.48
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
382
3646
1.06
0.46
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
111
1.35
0.46
1.1
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
221
0.77
0.46
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
221
0.77
0.46
1.3
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
49
1.43
0.46
2.1
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
49
422
1.17
0.45
1.3
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
220
0.77
0.45
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
220
0.77
0.45
1.3
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
22
174
1.27
0.45
1.5
1.9
pg
33.6
32.3
0.81
22
174
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
193
1.25
0.43
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
102
1121
0.90
0.43
1.9
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
122
1.31
0.42
2.6
2.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
6.7
—
0
10
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
132
1.29
0.40
2.2
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
49
427
1.15
0.40
1.3
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
18
141
1.28
0.40
1.1
1.3
e6/l
1228.6
1593.2
0.41
11
89
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
121
1114
1.09
0.40
1.4
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
88
1.37
0.40
1.8
1.4
promille
1.1
1.3
0.27
12
71
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
18
0.00
0.40
0.0
2.6
—
0.8
—
0
18
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
97
1.34
0.39
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
35
1.43
0.39
1.0
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
105
0.67
0.39
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
71
1.41
0.39
2.2
1.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
15
115
1.31
0.39
2.3
2.0
umol/l
5.7
7.1
—
9
75
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
66
1.37
0.38
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
31
261
1.19
0.38
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1423
14092
1.06
0.38
5.4
4.9
mmol/l
2.7
2.8
0.70
1312
12940
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
9
67
1.35
0.38
1.0
1.2
u/ml
—
14.6
—
0
9
(40768800) Prostate Pathology biopsy report
15
192
0.78
0.38
1.1
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
50
439
1.14
0.38
1.6
3.5
mg/l
43.5
73.1
0.97
42
360
(3029075) Extractable nuclear Ab panel - Serum
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1387
13730
1.05
0.36
5.1
4.4
mmol/l
1.5
1.5
3.27
1278
12597
(3008037) Lactate [Moles/volume] in Venous blood
26
310
0.84
0.36
5.0
3.1
mmol/l
1.3
1.5
0.73
26
300
(21494890) Protein electrophoresis panel - 24 hour Urine
11
146
0.75
0.36
1.8
2.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1494
14822
1.06
0.36
13.1
10.4
u/l
25.1
24.8
0.27
1447
14296
(40761511) CBC panel - Blood by Automated count
1461
14486
1.06
0.35
20.1
13.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
49
432
1.14
0.35
1.3
1.2
—
—
—
0
0
(44790047)
19
153
1.24
0.35
1.3
1.5
—
—
—
0
0
(44790048)
19
153
1.24
0.35
1.3
1.5
—
—
—
0
0
(44806118)
19
153
1.24
0.35
1.3
1.5
—
—
—
0
0
(44790049)
19
153
1.24
0.35
1.3
1.5
—
—
—
0
0
(4268621)
17
135
1.26
0.35
2.0
2.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
82
1.34
0.34
1.7
1.4
u/l
11.5
13.5
0.64
11
75
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
237
1.18
0.33
1.6
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
33
382
0.86
0.33
4.6
4.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
118
1.27
0.33
1.3
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
25
294
0.85
0.31
5.2
3.2
mmol/l
7.2
7.5
0.18
25
287
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
305
1.15
0.31
3.3
3.3
nmol/l
0.9
0.8
0.35
27
246
(3051387) C reactive protein [Mass/volume] in Capillary blood
35
306
1.15
0.30
4.5
3.6
mg/l
24.6
25.3
0.04
22
194
(3035320) C reactive protein [Mass/volume] in Body fluid
12
93
1.29
0.30
1.5
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
148
1.22
0.29
2.0
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1394
13824
1.05
0.29
5.0
4.4
mmol/l
4.7
4.7
0.53
1291
12767
(3007461) Platelets [#/volume] in Blood
1548
15391
1.06
0.29
29.4
20.9
e9/l
261.4
254.6
3.27
1519
15010
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.0
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
441
1.11
0.28
1.5
3.6
mg/l
36.9
58.6
0.79
42
363
(3017569) Oxygen content in Arterial blood
8
63
1.27
0.27
2.8
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
187
1.18
0.26
1.8
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
32
281
1.14
0.26
1.8
1.6
nmol/l
0.8
0.8
0.06
25
226
(3024731) MCV [Entitic volume]
1548
15398
1.06
0.26
29.3
20.8
fl
90.8
91.2
2.81
1524
15170
(3000012) Reticulocyte production index
10
77
1.30
0.26
1.1
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
118
1111
1.07
0.26
3.4
2.6
ml/min/173m2
70.7
66.8
0.54
52
461
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
132
1.21
0.25
1.1
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
1548
15400
1.06
0.25
29.3
20.7
pg
30.1
30.3
2.79
1526
15171
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
73
1.23
0.25
1.8
1.3
umol/l
12.1
27.6
—
9
66
(3044242) Glucose [Moles/volume] in Arterial blood
9
73
1.23
0.25
2.3
2.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
123
1.22
0.25
1.2
1.3
e6/l
60549.4
130528.6
—
9
63
(4027681)
9
74
1.22
0.25
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1548
15401
1.06
0.25
29.4
20.8
e12/l
4.4
4.4
1.62
1516
14968
(3009542) Hematocrit [Volume Fraction] of Blood
1249
12601
0.97
0.24
20.1
15.4
%
39.3
39.2
0.26
809
8900
(3010813) Leukocytes [#/volume] in Blood
1548
15404
1.05
0.24
29.5
20.9
e9/l
7.0
6.7
2.79
1516
14970
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
227
1.15
0.24
1.6
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
23
199
1.16
0.23
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
51
557
0.91
0.23
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
275
1.13
0.23
1.3
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
39
1.28
0.23
1.2
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1548
15407
1.05
0.22
29.7
21.0
g/l
131.9
133.5
4.64
1526
15172
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
79
1.27
0.22
1.5
1.9
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
144
1.18
0.22
1.1
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
229
1.14
0.21
1.1
1.4
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
4.1
—
0
6
(46235168) Fasting glucose [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
6.3
—
0
5
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
2.2
—
0.0
—
0
5
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
135
1.19
0.21
1.3
1.6
—
—
—
0
0
(3001729) Color of Synovial fluid
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(4212803)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
80
1.25
0.20
1.4
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
9
(3036071) Salmonella sp Ab [Titer] in Serum
6
48
1.25
0.20
1.7
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
99
1.21
0.19
1.8
1.5
g/l
0.9
1.0
0.48
12
99
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
52
1.15
0.19
1.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
137
1.17
0.18
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
58
1.21
0.18
1.1
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
11
91
1.21
0.17
2.9
2.0
ug/l
1.7
2.0
—
6
76
(3051593) INR in Capillary blood by Coagulation assay
7
61
1.15
0.17
10.9
13.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
176
1.14
0.17
1.6
2.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
111
1.17
0.15
1.3
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
78
1.15
0.15
1.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
121
1.16
0.15
1.1
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
121
1.16
0.15
1.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
121
1.16
0.15
1.1
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
74
704
1.05
0.14
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
253
2589
0.97
0.14
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
113
1.15
0.13
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
74
774
0.95
0.12
1.7
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
237
2422
0.98
0.12
4.2
4.4
%
20.1
21.2
0.60
113
1186
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
518
0.94
0.12
1.5
1.7
mg/l
3.5
3.9
0.13
36
374
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
50
527
0.95
0.11
1.5
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
153
1.11
0.11
1.7
1.9
pmol/l
161.5
195.6
1.01
17
141
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
1.2
1.2
nmol/l
7.0
30.6
—
5
30
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
46
1.09
0.09
1.2
1.3
ug/l
8.2
8.8
—
5
46
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1003
9974
1.01
0.09
4.3
3.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
57
1.05
0.08
1.5
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
61
0.82
0.08
2.6
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
154
0.91
0.08
1.9
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
156
1.09
0.08
1.8
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
44
421
1.05
0.08
1.3
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
9
85
1.06
0.07
1.1
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
88
1.02
0.07
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
23
216
1.07
0.06
1.3
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
138
1.09
0.06
1.3
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
110
1.09
0.05
1.1
1.1
—
—
—
0
0
(4034850)
45
436
1.03
0.05
11.8
10.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
130
1.08
0.04
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
30
312
0.96
0.04
1.4
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
91
1.10
0.04
8.0
6.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
34
328
1.04
0.04
1.5
3.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
60
587
1.02
0.03
6.8
3.7
%
48.2
47.7
0.05
60
577
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
20
209
0.96
0.03
1.7
1.8
nmol/l
41.5
41.2
0.02
20
200
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
382
3802
1.01
0.02
1.8
1.7
mmol/l
1.4
1.4
0.71
321
3201
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
303
3014
1.01
0.02
5.0
5.1
ug/l
2.4
2.9
0.82
273
2667
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
272
1.03
0.02
1.7
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
133
1.05
0.01
3.9
3.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
125
1.04
0.00
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
118
1.02
0.00
1.1
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
123
0.98
0.00
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
157
1.02
0.00
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
33
333
0.99
0.00
2.8
2.3
ug/min
160.7
107.2
0.23
17
200
(3019832) Treponema pallidum Ab [Presence] in Serum
90
905
0.99
0.00
1.6
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
50
1.00
0.00
1.0
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
0.00
0.0
1.1
—
7.8
—
0
9
(3035880) pH of Pleural fluid
7
70
1.00
0.00
1.1
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
37.5
—
0
9
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
21.9
—
0
9
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
71
0.99
0.00
1.4
1.4
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
8.5
—
0
9
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
13.6
—
0
8
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
71
0.99
0.00
1.4
1.4
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
54
0.93
0.00
1.0
1.6
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
6
0.00
-0.00
0.0
1.3
—
0.2
—
0
6
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint K11_OTHPERITON and mortality.

Females

Parameter HR [95% CI] p-value
K11_OTHPERITON 1.474 [1.29, 1.68] < 0.001
Birth year 0.994 [0.99, 1.0] 0.169

During the follow-up period (1.1.1998 — 31.12.2019), 542 out of 3633 females with K11_OTHPERITON died.

Males

Parameter HR [95% CI] p-value
K11_OTHPERITON 1.577 [1.33, 1.87] < 0.001
Birth year 0.988 [0.98, 1.0] 0.026

During the follow-up period (1.1.1998 — 31.12.2019), 305 out of 1141 males with K11_OTHPERITON died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHPERITON.

N-year risk Females Males
1 0.072% 0.306%
5 0.756% 1.774%
10 1.976% 4.635%
15 3.855% 8.783%
20 6.688% 14.661%

Relationships between endpoints

Index endpoint: K11_OTHPERITON – Other diseases of peritoneum

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data